ABSTRACT
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is one of the chronic liver diseases commonly found in the world. NAFLD is strongly associated with metabolic syndrome, including insulin resistance, diabetes, dyslipidaemia, and obesity. NAFLD may develop into liver cirrhosis and hepatoma. Prevalence of NAFLD is quite high in individuals with obesity, type 2 diabetes mellitus, and dyslipidaemia. NAFLD occurs in 60-95% obese patients, 28-55% type 2 diabetes mellitus patients, and 27-92% dyslipidaemia patients. 1 Liver biopsy remains a gold standard in determining the degree of NAFLD. However, liver biopsy frequently could not be performed in NAFLD patients due to some factors, such as: high cost, bleeding risk, and there is still no consensus to determine the histopathological criteria of NASH and differences in the degree of NAFLD. Currently, there are many modalities which can be used to detect the presence of steatosis.
Liver fibrosis can be evaluated non-invasively based on biological and physical approach. Biological approach means that by measuring biological markers which are measured from patients' serum and physical approach is performed by measuring the degree of liver stiffness by using transient elastography (TE). [2] [3] [4] TE is the most recent non-invasive diagnostic modality to (LSM). [5] [6] [7] [8] [9] [10] TE has high accuracy rate and can detect the presence of bridging fibrosis in patients with chronic liver disease. TE can also be applied in several chronic liver diseases, such as NAFLD, hepatitis B, primary biliary cirrhosis, sclerosing cholangitis, autoimmune hepatitis, alcoholic steatosis, and haemochromatosis. [11] [12] [13] [14] [15] [16] Liver stiffness measurement using TE is initiated by placing ultrasound transducer (probe) in the position in line with the vibrator axis. Vibrator will produce sound wave with low amplitude and frequency (50 Hz) which triggered the presence of elastic shear wave which later propagates as it traverses the underlying tissue. The degree of liver stiffness can be obtained from measuring sound wave velocity and its sound wave is propagated. Liver stiffness measurement using TE has several advantages compared to other modalities. First, TE is a non-invasive examination that can be performed quickly and painlessly. Second, TE may include tissue volume 100 times as big as liver biopsy tissue sample, thus it can picture the liver by extrahepatic abnormality, thus it does not need measurement results adjustments. 17 However, not all patients can give out liver stiffness measurement results using TE, due to the limitations it has. The main limitation of TE is associated with the characteristic propagation of elastic shear wave may stop before it Edi Mulyana, Irsan Hasan, Marcellus Simadibrata, Hamzah Shatri reaches liver tissue. Therefore, the success of TE will decrease in patients with ascites. Additionally, in obese patients, the skin to liver capsule distance (SCD) is larger; the subcutaneous tissue thickness can cause deviation of elastic shear wave before it reaches the liver tissue. This can decrease the accuracy and success in liver stiffness examination in patients with obesity. 18 Currently, new probe has been developed, which is XL probe. This new probe has undergone a series of clinical tests, which is believed may increase the success of liver stiffness measurement (LSM) particularly in patients with obesity. XL probe is lower frequency, larger amplitude of vibration, more sensitive transducer, and better depth of underskin measurement. A study showed that XL probe could increase the validity of measurement results than M probe, which was 45% to 76% (p < 0.001). 19 20 In the last six months, Hepatology Division Cipto Mangunkusumo Hospital found 27 patients who experienced failure of LSM from a total of 265 patients who underwent the examination. Therefore, the role of XL probe is expected to increase the success of LSM, although currently there is no study about XL probe in Indonesia. Therefore, a study to evaluate the success rate of liver stiffness measurement using XL probe in patients in Indonesia, particularly in the Division of Hepatology Cipto Mangunkusumo Hospital, is needed.
METHOD
The study design being used was cross sectional in NAFLD patients with obesity. Study was performed in Hepatology Division, Internal Medicine Department FMUI/Cipto Mangunkusumo Hospital Jakarta from 12 March 2013 until 12 June 2013. Target population in this study was all NAFLD patients with obesity, while accessible population was all NAFLD patients with obesity who visited Hepatology Polyclinic Cipto Mangunkusumo Hospital. Samples or subjects in this study were all NAFLD patients with obesity who visited Hepatology Polyclinic, Cipto Mangunkusumo Hospital from 12 March 2013 until 12 June 2013.
obese criteria, which is BMI > 25 kg/m 2 ; (2) Study USG results fatty liver was found and from anamnesis there was no history of alcohol consumption or alcohol consumption not exceeding 70 g/week for female and 140 g/week for male; (3) Study subjects were willing to participate in the study. Exclusion criteria were: (1) Presence of ascites from the abdominal USG results; (2) Study subjects had skin disease and thus, transient elastography was not possible to be performed to them; (3) Presence of mass in the chest wall or local abnormality in the liver tissue including liver abscess or hepatoma. Sample collection was performed by total sampling, criteria in the general subject group in the determined period. The minimum sample size was 67 patients. Because the same subject received two interventions, control group was the same group. Therefore, the minimum sample size in this study after the additional 10% for drop outs were 56 patients or was rounded to 60 patients. All obese patients who visited the Hepatology Polyclinic FMUI/Cipto Mangunkusumo Hospital from 12 March 2013 to 12 June 2013. In a consecutive manner, to these patients, several examinations were performed, including body weight, body height, body mass index, abdominal USG, SCD, and thoracic examination using M and XL probes. Examination was performed to patients on supine position (dorsal decubitus) by placing probe on the intercostal space that faced the central part of the right lobe of the liver, which was 8-10 th intercostal space in the axillary line by positioning the right arm in the maximal abduction position. Probe in the perpendicular position towards the skin surface. Examination was considered to be successful if there were ten valid measurement results with the success rate > 60% and IQR/M < 0.3.
Data collected from this study were then analysed and presented in tabular and figure forms. Data analyses were performed through analytic descriptive using SPSS computer programme version 11. consecutively underwent several examinations, including antopometric examination (body weight, body height, and thoracic circumference) and abdominal USG which were then followed with TE examination using M and XL probes.
RESULTS
During the period of this study, we obtained 92 respondents of NAFLD patients with obesity who performed according to the study pathway. We found that there were more female patients (82.6%) compared to male (17.4%), average patients' age 44.3 ± 10.2 years old. The median value of BMI and SCD were 31.5 kg/m 2 and 2.3 cm, respectively. The mean value of thoracic circumference was 94.7 S ± 8.2 cm. These data were presented in Table 1 .
In concordance with the objectives, in this study, we performed examinations towards some factors thought to be associated with the success of liver stiffness measurement using M and XL probe. Factors being studied include BMI, SCD, and thoracic circumference. To identify the difference of mean in The proportion of success rate in the liver stiffness measurement using M probe was 57.6% (53 patients), while the proportion of success rate in liver stiffness measurement using XL probe was 88% (81 patients). This was shown in Table 2 . To know the proportion comparison of the success rate in liver stiffness measurement using M and XL probes, we performed McNemar statistical test. The obtained result was p value < 0.001. This could be seen in Table 3 . From Table 4 , it could be seen that BMI, SCD, and thoracic circumference were associated with the success of liver stiffness measurement using M probe. 0.007, 0.001 and 0.001, respectively. The mean value of thoracic circumference to which liver stiffness measurement was not succeed to be performed using the M probe was 97.8 cm. In addition, the median value of BMI and SCD to which liver stiffness measurement was not succeed to be performed using M probe was 32.7 kg/m 2 and 2.6 cm. 16 The median value of BMI and SCD were 40.5 kg/m 2 and 2.8 cm. Myers et al studied 276 CLD patients with 63% of them were male patients. 31 The median value of BMI, SCD, and thoracic circumference were 30 kg/ m 2 , 2.20 cm, and 105 cm, respectively. The percentage of patients whose liver stiffness measurement were unreliable using transient elastography varied from 2% to 10%, generally caused by obesity. In this study, the proportion of failure in liver stiffness measurement using M probe was 42.4% (39 patient). This could possibly be caused by the obese criteria used in this study (BMI > 25), therefore this failure was associated with the subcutaneous fat tissue and connective tissue thickness which were located between the probe and the liver. 19, 23 In this study, failure of liver stiffness measurement using XL probe was 12% (11 patients). Six from those eleven patients had BMI > 30 and 3 patients among them had SCD > 3.5.
This was in line with the fact that XL probe was suggested to be used in SCD > 2.5 cm and < 3.5 cm. 18 Four patients whose measurement failed using the XL probe had body height < 150 cm; the failure could be associated with the narrow intercostal space. In this study, the success of liver stiffness measurement using XL probe was higher (88%) compared to the M probe This was consistent with the advantage of XL probe (with lower frequency, higher amplitude, and larger depth of measurement), thus could increase the success of liver stiffness measurement in obese patients.
This study obtained the success rate of liver stiffness measurement with the proportion of XL probe as much as 88% and proportion of M probe was 57.6%. Different from previous study by Ledinghen et al who studied 99 obese patients with BMI > 30, in which the results were success in liver stiffness measurement using M probe 45% and 75% in XL probe. 16 This could possibly happen due to the higher average value of BMI and SCD in the study conducted by Ledinghen et al compared to the values obtained in this study, which were BMI 40.5 kg/m 2 and SCD 2.8 cm. The results of this study was not of much difference with 31, 32, 33 In this study, we found that BMI, SCD, and thoracic circumference factors were related with the success of liver stiffness measurement using M with p value of 0.007, 0.001, and 0.001, respectively. These results were different with the study conducted by Ledinghen et al, in which only SCD and thoracic circumference were associated with the success of liver stiffness measurement using M probe. 16 This could possibly be caused by the different obesity criteria being used in the study. In this study, we used the Asia 2 , while in the study performed by Ledinghen et al, they used WHO criteria, which was obesity if BMI > 30 kg/ m 2 . Therefore, the average value of BMI was higher, particularly 40.5 kg/m 2 . Similar with the study done by Foucher et al, in which the results were BMI factor > 28 which was associated with failure of liver stiffness measurement with p value = 0,001. 23 Different results were also found in the study conducted by Ledinghen et al, in which age and BMI > 30 were associated with the success of liver stiffness measurement using M probe and only BMI > 30 factor was associated the success of liver stiffness measurement using XL probe. 20 Results and central obesity were factors associated with the failure of liver stiffness measurement. 33 In this study, it was revealed that BMI, SCD, and associated with the success rate of liver stiffness measurement using XL probe with p value of 0.321, 0.817 and 0.216, respectively. This was because in this study 88% patients (81 patients) succeed to undergo liver stiffness measurement using XL probe. Therefore, in this study, those factors could be overcome by XL probe. This condition showed that XL probe in this study was better in measuring liver stiffness compared to M probe in NAFLD patients with obesity. The results of this study were different from the study performed by Ledinghen et al. 19 This study revealed that SCD factor was associated with the success rate of liver stiffness measurement using the XL probe. This could possibly be caused by the higher average value of SCD obtained in their study, which was 2.8 cm. From t-test statistical test as shown in Table 4 , we found that the mean of thoracic circumference to whom liver stiffness measurement failed to be obtained using M probe was 97.8 cm. Using the Mann-Whitney test, also as shown in Table 4 , we found that the median value of BMI and SCD to whom liver stiffness measurement failed to be obtained using the M probe were 32.7 kg/m 2 and 2.6 cm, respectively. This was in concordance with the fact that liver stiffness measurement using M probe performed in patients with BMI with normal body weight and SCD < 2.5 cm and in SCD from 2.5-3.5 were suggested to use the XL probe.
CONCLUSION
The success rate of liver stiffness measurement using success of liver stiffness measurement by using TE were BMI, SCD, and thoracic circumference. To increase the success of liver stiffness measurement, in NAFLD patients with obesity whose BMI, SCD, and thoracic circumference were more than 32.7 kg/m 2 , 2.6 cm and 97.8 cm, it would be better to use the XL probe. The results of this study could be used as a baseline for further studies in larger research scale to determine the cut-off and predictor model towards factors which
